Menu

AbbVie and GSK announced they will refund 340B providers for certain medications following ceiling price recalculations.

AbbVie, GSK Announce Refunds for 340B Overcharges

November 13, 2024 Bella Czajkowski, National Correspondent 340B Report Views

Drugmakers AbbVie and GlaxoSmithKline (GSK) will refund 340B providers for some products following ceiling price recalculations, according to notices posted [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Bella Czajkowski

Column: Post Election Analysis: Implications for the 340B Program

Tammy Kinney: A Personal Testament to 340B’s Importance in Rural America